NEWS      WELCOME      CONTACT EMN      EMN SO      EMN TRIALS      EMN TRIAL GROUP      EMN BIOLOGY GROUP      LOGIN      MSCNET

 Updated on: Jan 9 2014

EMN Trials

 is titled:

 

" A randomixed European Phase III study on the efficacy of first line Dexamethasone, Rituximab and Cyclophosphamide (DRC) +/- Bortezomib
for patients with Waldenström Macroglobulinemia".

 

Read synopsis of the study here.

Secr. Hans E. Johnsen | Depart. of Haematology | Aalborg University Hospital | Sdr. Skovvej 15 | DK-9000 Aalborg | Denmark | T:+45 9766 3871 | F:+45 9766 6369